The American College of Gastroenterology created guidelines to provide clinicians with evidence supporting the optimal management of patients with irritable bowel syndrome.
A team of investigators sought to identify potential links between gut microbes and symptoms of irritable bowel syndrome.
Investigators evaluated the prevalence of small intestinal bacterial overgrowth (SIBO) in a well-defined cohort of patients with functional dyspepsia (FD) using quantitative microbiological assessment of the duodenal aspirate.
Investigators sought to identify common GI symptoms in a large sample of “emerging adults” using the Patient-Reported Outcomes Measurement Information System – GI (PROMIS-GI) symptom scales.
Celiac disease in children leads to an increased risk for functional constipation and irritable bowel syndrome compared with healthy controls.
Asthma and food hypersensitivity (FH) at age 12 years are associated with an increased risk for irritable bowel syndrome at age 16 years.
Researchers compared integrated multidisciplinary clinical care vs gastroenterologist-only care with regard to symptoms, specific functional disorders, psychological state, quality of life, and cost of care for treating functional gastrointestinal disorders.
The study aimed to determine the prevalence of adverse pregnancy outcomes associated with biologic use in women with IBD.
Investigators examined the diagnostic yield of colonoscopies for patients with functional bowel disorders without alarm features.
Researchers assessed malignancy frequency in the tofacitinib ulcerative colitis clinical development program, along with frequency of malignancy events and rates.
Treatments guided by metagenomics may result in symptom improvement for patients with irritable bowel syndrome.
Use of acupuncture reduced total irritable bowel syndrome-Symptom Severity Score to a greater extent than use of other pharmacologic therapies.
Probiotics should only be recommended for specific patient populations since there is not enough evidence to support their use in the majority of digestive conditions, according to new clinical guidelines released by the American Gastroenterological Association (AGA) and recently published in Gastroenterology.
A novel study examines the relationship between acne vulgaris and irritable bowel syndrome.
Lower total hospitalization costs were identified in patients with IBS who used cannabis compared with patients who did not use cannabis.
Use of a heat-inactivated form of a probiotic was associated with significant reduction in abdominal pain as well as relief of symptoms in patients with irritable bowel syndrome.
Mindfulness-based stress reduction training is associated with robust improvements in gastrointestinal symptoms for patients with irritable bowel syndrome.
The FDA has approved a new version of Axonics Modulation’s rechargeable implantable sacral neurostimulator (r-SNM) system that allows patients to decrease the frequency of charging to once a month.
Probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome.
A commonly used over-the-counter treatment for IBS is peppermint oil. The exact mechanism of action in IBS is not entirely known; however, it has been postulated that it may be mediated through smooth muscle relaxation, antimicrobial effects, modulation of pain receptors, and 5-hydroxytryptamine antagonism.